EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Experience of living with psoriasis in Brazil: a Global Psoriasis Atlas online survey

Jaquelini Barboza da Silva, Alison K Wright iD, André V E Carvalho, Christopher E M Griffiths, Darren M Ashcroft

International Journal of Dermatology · 2025

DOI: 10.1111/ijd.17387 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Dermatology, 2025. Verfasst von Jaquelini Barboza da Silva und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, University of Santa Cruz do Sul, Santa Cruz do Sul, Brazil. Hauptthemen laut MEDLINE: Psoriasis, Quality of Life. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Global Psoriasis Atlas (GPA), LEO Foundation, Boehringer Ingelheim.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Psoriasis significantly burdens patients' lives, but there is limited data on this in Brazil.

Methods

Between May 2022 and January 2023, we conducted a cross‐sectional online survey of 563 Brazilian residents aged ≥18 years who had been diagnosed with psoriasis. Spearman's correlation ( r ) was used to test the correlation between self‐assessed disease severity (Simplified Psoriasis Index [saSPI] extent score; range 0 [clear/minor] to 40 [widespread/severe]) and health‐related quality of life (QoL, score of 1 means perfect health) and capability (ICECAP‐A: score of 1 means full capability) measures. Multivariable linear regression was used to identify predictors of QoL and capability. A thematic analysis examined the free‐text responses and identified common themes.

Results

The mean age of participants was 42.1 ± 12.4 years, and over half had at least one other long‐term condition. The mean QoL score was 0.59 ± 0.25, and the mean capability score was 0.71 ± 0.21. At the time of survey completion, over 80% of respondents reported some level of pain and/or discomfort, and 86% reported feeling anxious and/or depressed. The mean self‐assessed saSPI was 7.8 ± 8.6, which negatively correlated with health‐related QoL ( r = −0.49, P < 0.05) and capability ( r = −0.44, P < 0.05). Significant predictors of poorer QoL and reduced capability included high saSPI, number of psoriasis flares and comorbidities, female gender, Black ethnicity, and employment status (unemployed, long‐term sick). Frequently reported areas that impacted patients were social stigma/prejudice, powerlessness, lack of education and public awareness, and difficulty obtaining appropriate care/treatment.

Conclusions

We found that the clinical manifestations, severity, and associated comorbidities of psoriasis negatively impacted health‐related QoL and capability, along with feelings of stigmatization and barriers to specialist treatment. This highlights the need for better access to care and awareness of the disease to improve the lives of people living with psoriasis in Brazil.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisQuality of LifeHumansBrazilMaleFemaleAdultMiddle AgedCross-Sectional StudiesSeverity of Illness IndexYoung AdultSurveys and QuestionnairesAgedSocial StigmaAdolescent

Stichwörter der Autor:innen

access to careinflammatory diseasespsoriasisquality of lifesocial stigma

Autor:innen und Institutionen

  • Department of Life Sciences, University of Santa Cruz do Sul, Santa Cruz do Sul, Brazil.
  • Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, NIHR Manchester Biomedical Research Centre, University of Manchest…
  • Psoriasis Outpatient Clinic, Hospital Moinhos de Vento, Porto Alegre, Brazil.
  • Centre for Dermatology Research, NIHR Manchester Biomedical Research Centre, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
  • Department of Dermatology, King's College Hospital, King's College London, London, UK.

ORCID-Profile: Alison K Wright

Förderung

  • Global Psoriasis Atlas (GPA)
  • LEO Foundation
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Janssen
  • LEO Fondet
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb

Zitieren

APA

Silva, J. B. D., Wright, A. K., Carvalho, A. V. E., Griffiths, C. E. M., & Ashcroft, D. M. (2025). Experience of living with psoriasis in Brazil: a Global Psoriasis Atlas online survey. International Journal of Dermatology. https://doi.org/10.1111/ijd.17387

Vancouver

Silva JBD, Wright AK, Carvalho AVE, Griffiths CEM, Ashcroft DM. Experience of living with psoriasis in Brazil: a Global Psoriasis Atlas online survey. International Journal of Dermatology. 2025. doi:10.1111/ijd.17387

BibTeX
@article{Silva2025,
  author = {Silva, Jaquelini Barboza da and Wright, Alison K and Carvalho, André V E and Griffiths, Christopher E M and Ashcroft, Darren M},
  title = {Experience of living with psoriasis in Brazil: a Global Psoriasis Atlas online survey},
  journal = {International Journal of Dermatology},
  year = {2025},
  doi = {10.1111/ijd.17387}
}
Kostenlos starten →